Improving anti-CTLA-4 therapies through peptide masking and Fc non-fucosylation: preclinical characterization of three novel antibodies

Amy Jhatakia(Sequoia Hospital), Tina Cascone(The University of Texas MD Anderson Cancer Center), Alan J. Korman(Bristol-Myers Squibb (Germany)), Arnab Mukhopadhyay(National Institute of Immunology), Joshua Dobroff(Sequoia Hospital), Clémence Leung, Manik Pradhan(S.N. Bose National Centre for Basic Sciences), Courtni Newsome(The Bristol-Myers Squibb Children's Hospital), Mohammed Nasser(Sequoia Hospital), Sheila F. O’Brien(University of Ottawa), Ke Xu(Shanxi Medical University), Felix Findeisen(Sequoia Hospital), Muhammad Sajid Yazdani, Nidhi Gupta(National Research Centre for the Working Environment), Yuquan Wei(Sichuan University), Remie Gail Z. Mandawe(Sequoia Hospital), Min Wang(Central South University), Lili Chen(University of South China), Xin Sun(Jiangsu University of Science and Technology), Kai Kang(Guangdong Ocean University), Hongwei Lin, Nicholas Wilson(Sequoia Hospital), M. J. Selby, L L Leung(Gilead Sciences (United States)), Jack Lohre(Sequoia Hospital), Hui Guo, Karen Price(Purchase College), Amy Hammell(Bristol-Myers Squibb (United States)), Wei Hu(Chinese Academy of Tropical Agricultural Sciences), J. Le, Jeffery A. Engelhardt

immuneACCESS

April 15, 2025

Cited by 0

Related Papers

|New England Journal of Medicine|2012|12.6k

|New England Journal of Medicine|2012|8k

|New England Journal of Medicine|2013|4.2k

|Science|2002|2.9k

|Nature Genetics|2014|780